Radcliffe Capital Management’s DPCM Capital, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at XPOA.WS Stock Holding History

Radcliffe Capital Management’s Portfolio XPOA.WS Stock Details XPOA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-99,284	Closed	-$984K	–	1256
2022 Q2	$984K	Hold	99,284	–	–	0.02%	983
2022 Q1	$982K	Hold	99,284	–	–	0.02%	973
2021 Q4	$975K	Hold	99,284	–	–	0.03%	848
2021 Q3	$970K	Hold	99,284	–	–	0.03%	719
2021 Q2	$981K	Hold	99,284	–	–	0.03%	728
2021 Q1	$979K	Buy	+99,284	New	+$211K	0.04%	588

Radcliffe Capital Management's XPOA.WS Position: Q3 2022 in Review

Radcliffe Capital Management sold out of DPCM Capital, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at (XPOA.WS) in Q3 2022, closing a stake of 99,284 shares — an estimated $984K sold.

Radcliffe Capital Management first reported a position in XPOA.WS in Q1 2021 and held it in 6 quarters. The position peaked at $984K in Q2 2022. 0 funds tracked by Wall St. Rank hold XPOA.WS as of Q3 2022.

Radcliffe Capital Management reported no remaining DPCM Capital, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at position as of Q3 2022 after selling out during the quarter.
Radcliffe Capital Management sold 99,284 DPCM Capital, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at shares in Q3 2022, an estimated $984K.
Radcliffe Capital Management first reported a position in DPCM Capital, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at in Q1 2021 and held it in 6 quarters.
Radcliffe Capital Management's DPCM Capital, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at position peaked at $984K in Q2 2022.
0 funds tracked by Wall St. Rank held DPCM Capital, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at as of Q3 2022.

Based on Radcliffe Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.